Analyst Ranking
Top 16%
#786 out of 4937 analysts
Average Return
+7.49%
Win Rate
59%48 out of 81
Risk vs Reward
Poor
Good

Tycho Peterson's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Envista Holdings CorpNVST
+160.08%$15.78$41.04
2020-03-17 -
2021-03-17
Strong Buy
Invitae CorpNVTAQ
+156.98%$6.09$15.65
2018-02-13 -
2019-02-13
Strong Buy
Natera IncNTRA
+134.04%$43.51$101.83
2020-05-07 -
2021-05-07
Strong Buy
Hologic IncHOLX
+127.74%$31.47$71.67
2020-03-17 -
2021-03-17
Strong Buy
Pacific Biosciences Of California IncPACB
+118.19%$11.71$25.55
2020-10-02 -
2021-09-30
Strong Buy

Tycho Peterson's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Agilent Technologies IncA
4Strong Buy$155.00+25.73%Maintains
a month ago
Genedx Holdings CorpWGS
1Strong Buy$80.00-3.10%Upgrades
2 months ago
Quidelortho CorpQDEL
4Strong Buy$44.00+45.02%Upgrades
2 months ago
Mettler Toledo International IncMTD
4Hold$1,100.00-10.13%Upgrades
2 months ago
Danaher CorpDHR
3Strong Buy$260.00+26.92%Maintains
3 months ago
Labcorp Holdings IncLH
2Strong Buy$290.00+16.18%Maintains
5 months ago
Neogenomics IncNEO
1Strong Buy$22.00+203.03%Initiates Coverage On
7 months ago
Quest Diagnostics IncDGX
1Strong Buy$185.00+10.06%Assumes
7 months ago
Hologic IncHOLX
2Hold$85.00+29.34%Initiates Coverage On
7 months ago
Qiagen NvQGEN
5Strong Buy$54.00+12.20%Assumes
7 months ago
Waters CorpWAT
2Strong Buy$415.00+17.59%Upgrades
9 months ago
Twist Bioscience CorpTWST
2Strong Sell$35.00-7.97%Maintains
a year ago
Revvity IncRVTY
1Hold$125.00+23.15%Maintains
a year ago
10x Genomics IncTXG
4Strong Buy$24.00+87.50%Upgrades
a year ago
Pacific Biosciences Of California IncPACB
2Strong Buy$4.00N/AInitiates Coverage On
a year ago
Nautilus Biotechnology IncNAUT
1Hold$3.00N/AAssumes
a year ago
Natera IncNTRA
2Strong Buy$142.00N/AInitiates Coverage On
a year ago
Guardant Health IncGH
2Strong Buy$32.00N/AInitiates Coverage On
a year ago
Illumina IncILMN
1Hold$115.00N/AAssumes
a year ago
Myriad Genetics IncMYGN
1Sell$20.00N/AAssumes
a year ago
Thermo Fisher Scientific IncTMO
6Strong Buy$650.00N/AAssumes
a year ago
Syneos Health IncSYNH
1Hold$53.00N/ADowngrades
3 years ago
Sotera Health CoSHC
1Strong Sell$9.00N/ADowngrades
3 years ago
Rapid Micro Biosystems IncRPID
2HoldN/AN/ADowngrades
3 years ago
Seer IncSEER
2Hold$12.00N/ADowngrades
3 years ago
Phenomex IncCELL
2Hold$8.00N/ADowngrades
3 years ago
Zymergen IncZY
4HoldN/AN/AUpgrades
3 years ago
Quanterix CorpQTRX
2Strong Buy$60.00N/AMaintains
3 years ago
Nanostring Technologies IncNSTGQ
1Strong Buy$70.00N/AMaintains
3 years ago
Talis Biomedical CorpTLIS
3Strong Sell$105.00N/ADowngrades
4 years ago
Sophia Genetics SaSOPH
1Strong Buy$23.00N/AInitiates Coverage On
4 years ago
Singular Genomics Systems IncOMIC
1Strong Buy$900.00N/AInitiates Coverage On
4 years ago
Charles River Laboratories International IncCRL
2Strong Buy$390.00N/AMaintains
4 years ago
Akoya Biosciences IncAKYA
1Strong Buy$23.00N/AInitiates Coverage On
4 years ago
Ppd IncPPD
2Hold$48.00N/ADowngrades
4 years ago
Invitae CorpNVTAQ
2Hold$45.00N/ADowngrades
5 years ago
Orasure Technologies IncOSUR
1Hold$18.00N/AInitiates Coverage On
5 years ago
Intuitive Surgical IncISRG
9Strong Buy$200.00N/AMaintains
5 years ago
Varian Medical Systems IncVAR
4Strong Sell$90.00N/AMaintains
5 years ago
Envista Holdings CorpNVST
1Strong Buy$27.00N/AMaintains
5 years ago
Dentsply Sirona IncXRAY
4Hold$45.00N/AMaintains
5 years ago
Genmark Diagnostics IncGNMK
1Hold$7.00N/ADowngrades
6 years ago
Accelerate Diagnostics IncAXDXQ
4Strong Sell$160.00N/ADowngrades
6 years ago
Repligen CorpRGEN
2Strong Buy$70.00N/AMaintains
7 years ago
Iqvia Holdings IncIQV
1Strong Buy$120.00N/AMaintains
7 years ago
Genomic Health IncGHDX
1Strong SellN/AN/ADowngrades
8 years ago
Accuray IncARAY
1Strong SellN/AN/ADowngrades
8 years ago
Patheon NvPTHN
1HoldN/AN/ADowngrades
8 years ago
Albany Molecular Research IncAMRI
1HoldN/AN/ADowngrades
8 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.